Amedeo Smart

Free Medical Literature Service

 

Amedeo

Chronic Heart Failure
  Free Subscription

Articles published in
Am Heart J
    November 2025
  1. DEVASENAPATHY N, Biswas S, Kini P, Satheesh S, et al
    Digoxin in rheumatic heart disease: Rationale and design of a multicenter, placebo-controlled double-blind randomized controlled trial (Dig-RHD trial).
    Am Heart J. 2025;289:38-47.
    >> Share

    October 2025
  2. RAMBARAT P, Erickson T, Cyr D, Ward J, et al
    Effects of angiotensin-neprilysin inhibition in women vs men: Insights from PARAGLIDE-HF.
    Am Heart J. 2025;288:41-51.
    >> Share

    September 2025
  3. WONG J, Smith J, Soh CH, Howden E, et al
    Risk-Guided Disease Management To Prevent Heart Failure In Adult Cancer Survivors of Previous Cardiotoxic Cancer Treatments: Baseline Results of the REDEEM Trial.
    Am Heart J. 2025 Sep 16:S0002-8703(25)00331-X. doi: 10.1016/j.ahj.2025.
    >> Share

  4. GOLDENBERG I, Zareba W, Ezekowitz JA, Albert C, et al
    Rationale and Design of the Comparative Effectiveness of ICD Versus Non-ICD Therapy in Contemporary Heart Failure Patients at a Low Risk for Arrhythmic Death (CONTEMP-ICD) trial.
    Am Heart J. 2025 Sep 4:S0002-8703(25)00320-5. doi: 10.1016/j.ahj.2025.
    >> Share

    July 2025
  5. ILONZE OJ, Helmkamp LJ, McIlvennan CK, Allen LA, et al
    Trends in Urine Drug Screening and Positivity Among Patients with Heart Failure: Insights from a Large Health System.
    Am Heart J. 2025 Jul 10:S0002-8703(25)00216-9. doi: 10.1016/j.ahj.2025.
    >> Share

  6. KARSTEN M, Vignati C, Pezzuto B, Apostolo A, et al
    Accurate Fick cardiac output estimation: direct and simultaneous oxygen consumption measurement is imperative in heart failure.
    Am Heart J. 2025 Jul 9:S0002-8703(25)00209-1. doi: 10.1016/j.ahj.2025.
    >> Share

    June 2025
  7. HANIF M, Khan LA, Kulkarni A, Bhatia HS, et al
    Global lipoprotein (a) testing trends from 2015 to 2023.
    Am Heart J. 2025 Jun 21:S0002-8703(25)00199-1. doi: 10.1016/j.ahj.2025.
    >> Share

  8. HOPPER I, Marwick TH, Wolfe R, Amerena J, et al
    STAREE-HEART: a randomized placebo-controlled trial of atorvastatin effects on a marker of cardiac aging in older individuals without prior cardiovascular disease events: Protocol and baseline description of participants.
    Am Heart J. 2025 Jun 12:S0002-8703(25)00193-0. doi: 10.1016/j.ahj.2025.
    >> Share

  9. ZIMERMAN A, Dal Forno A, Rohde LE, Ternes CMP, et al
    Conduction System Pacing vs. Biventricular Resynchronization in Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block: Rationale and Design of the PhysioSync-HF Trial.
    Am Heart J. 2025 Jun 3:S0002-8703(25)00191-7. doi: 10.1016/j.ahj.2025.
    >> Share

  10. KHAN MS, Sauer AJ, Green CL, McDermott J, et al
    Rationale, Design, and Baseline Characteristics of the Virtual Care to Improve Heart Failure Outcomes (VITAL-HF) Trial.
    Am Heart J. 2025 Jun 3:S0002-8703(25)00190-5. doi: 10.1016/j.ahj.2025.
    >> Share

    May 2025
  11. KITTIPIBUL V, Cyr DD, Harrington J, Lala A, et al
    Structural Abnormalities and Effects of Sacubitril/Valsartan in Patients with Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure: The PARAGLIDE-HF Trial.
    Am Heart J. 2025 May 22:S0002-8703(25)00161-9. doi: 10.1016/j.ahj.2025.
    >> Share

  12. SZABO-SODERBERG B, Benson L, Savarese G, Hage C, et al
    Loop and thiazide diuretics and outcomes in heart failure with preserved ejection fraction.
    Am Heart J. 2025 May 6:S0002-8703(25)00155-3. doi: 10.1016/j.ahj.2025.
    >> Share

    April 2025
  13. KITTIPIBUL V, Novelli A, Yaranov D, Swavely A, et al
    Relationship of Red Blood Cell Mass Profiles and Anemia Type to Outcomes and Cardiopulmonary Exercise Performance in Chronic Heart Failure.
    Am Heart J. 2025 Apr 28:S0002-8703(25)00143-7. doi: 10.1016/j.ahj.2025.
    >> Share

  14. PETERS AE, Li S, Cyr D, Williamson KM, et al
    Influence of ejection fraction on outcomes with sacubitril/valsartan in patients with worsening heart failure with EF>40%: The PARAGLIDE-HF Trial.
    Am Heart J. 2025 Apr 21:S0002-8703(25)00139-5. doi: 10.1016/j.ahj.2025.
    >> Share

  15. DUPRE ME, Dhingra R, Xu H, Hammill BG, et al
    Racial and ethnic disparities in longitudinal trajectories of hospitalizations in patients diagnosed with heart failure.
    Am Heart J. 2025 Apr 8:S0002-8703(25)00123-1. doi: 10.1016/j.ahj.2025.
    >> Share

    March 2025
  16. CHEN Y, Lawrence J, Stockbridge N
    Corrigendum to "Days alive out of hospital in heart failure: Insights from the PARADIGM-HF and CHARM trials" [Am Heart J 241 (2021) 108-119].
    Am Heart J. 2025;285:105.
    >> Share

  17. ZEYMER U, Hassinger F, Bramlage P, Schafer A, et al
    Hyperoxemic Oxygen Therapy in Patients with Acute Anterior Myocardial Infarction: HOT-AAMI - Design and Rationale of a Randomized Trial.
    Am Heart J. 2025 Mar 21:S0002-8703(25)00095-X. doi: 10.1016/j.ahj.2025.
    >> Share

  18. YU J, Indraratna P, Briggs NE, Brown P, et al
    Rationale and design of the TeleClinical Care (TCC) -Cardiac trial: A pragmatic randomized trial of adjunctive virtual models of care in the secondary prevention of cardiovascular events.
    Am Heart J. 2025 Mar 11:S0002-8703(25)00091-2. doi: 10.1016/j.ahj.2025.
    >> Share

  19. DONAZZAN L, Bulian F, Maines M, Erckert M, et al
    Effect of rate-adaptive atrial support compared to VDD pacing in cardiac resynchronization therapy recipients: A randomized cross-over study.
    Am Heart J. 2025;281:149-156.
    >> Share

  20. HARRINGTON J, Leyva M, Rao VN, Oakes M, et al
    Implementing guideline-directed medical therapy: Stakeholder-identified barriers and facilitators.
    Am Heart J. 2025;281:23-31.
    >> Share

    February 2025
  21. TAKAHASHI T, Wei J, Iribarren AC, Gulati M, et al
    Rationale and design of the Women's Ischemia Syndrome Evaluation Mechanisms of Coronary Microvascular Dysfunction Leading to Pre-Heart Failure With Preserved Ejection Fraction (WISE Pre-HFpEF).
    Am Heart J. 2025 Feb 24:S0002-8703(25)00056-0. doi: 10.1016/j.ahj.2025.
    >> Share

  22. PASQUALIN G, Misra A, Gauvreau K, Sanders SP, et al
    Ventricular-Arterial Coupling is associated with Clinical Outcomes in Patients with Systemic Right Ventricle.
    Am Heart J. 2025 Feb 19:S0002-8703(25)00043-2. doi: 10.1016/j.ahj.2025.
    >> Share

  23. SHOJI S, Cyr DD, Hernandez AF, Velazquez EJ, et al
    Win Ratio Analyses Using a Modified Hierarchical Composite Outcome: Insights From PARAGLIDE-HF.
    Am Heart J. 2025;280:70-78.
    >> Share

    January 2025
  24. KREINBROOK J, Rego E, Schlichte L, Barnes S, et al
    Towards a Person-Centered After-Visit Summary to Facilitate Improved Heart Failure Care (HF-AVS): A Scoping Review and Call to Action.
    Am Heart J. 2025 Jan 29:S0002-8703(25)00014-6. doi: 10.1016/j.ahj.2025.
    >> Share

  25. BALDI C, Maio MD, Esposito L, Bellino M, et al
    How the COAPT trial affected the selection of patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair: insights from the GIOTTO Registry.
    Am Heart J. 2025 Jan 27:S0002-8703(25)00011-0. doi: 10.1016/j.ahj.2025.
    >> Share

  26. CHAIKIJURAJAI T, Chen HH, Tang WHW
    Baseline NT-proBNP Non-Response Score and Health Status Measures in Assessing Treatment Responses in Heart Failure with Reduced Ejection Fraction.
    Am Heart J. 2025 Jan 25:S0002-8703(25)00012-2. doi: 10.1016/j.ahj.2025.
    >> Share

  27. SHECHTER A, Gupta A, Kaewkes D, Taheri H, et al
    Implications of an Off-Hours Setting in Patients Undergoing Transcatheter Edge-to-Edge Repair for Mitral Regurgitation.
    Am Heart J. 2025 Jan 2:S0002-8703(24)00341-7. doi: 10.1016/j.ahj.2024.
    >> Share

    December 2024
  28. BULLOCK G, Jacobs JA, Carey JR, Pan IZ, et al
    Patterns of diuretic titration during inpatient management of acute decompensated heart failure.
    Am Heart J. 2024 Dec 27:S0002-8703(24)00339-9. doi: 10.1016/j.ahj.2024.
    >> Share

  29. ZHOU K, Alemayehu W, Rathwell S, McAlister FA, et al
    The Relationship of Diuretics and Dietary Sodium in Patients with Heart Failure: An Analysis of the SODIUM-HF Trial.
    Am Heart J. 2024 Dec 4:S0002-8703(24)00321-1. doi: 10.1016/j.ahj.2024.
    >> Share

  30. HWANG CS, Desai RJ, Kesselheim AS, Levin R, et al
    Primary Medication Adherence in Medicare Beneficiaries Prescribed Sacubitril-Valsartan or Renin-Angiotensin System Blockers for Heart Failure with Reduced Ejection Fraction.
    Am Heart J. 2024 Dec 3:S0002-8703(24)00316-8. doi: 10.1016/j.ahj.2024.
    >> Share

    October 2024
  31. MAIDMAN SD, Blecker S, Reynolds HR, Phillips LM, et al
    Cardiologist Perceptions on Automated Alerts and Messages To Improve Heart Failure Care.
    Am Heart J. 2024 Oct 16:S0002-8703(24)00269-2. doi: 10.1016/j.ahj.2024.
    >> Share

  32. BALGOBIND A, Pierce M, Alviar C, Barnett C, et al
    Current practices in the management of temporary mechanical circulatory support: A survey of CICU directors in North America.
    Am Heart J. 2024;276:115-119.
    >> Share

    September 2024
  33. QAZI SU, Hamid A, Ansari HUH, Khouri MG, et al
    Trends in Cancer and Heart Failure related mortality in adult US population: A CDC WONDER database analysis from 1999 to 2020.
    Am Heart J. 2024 Sep 17:S0002-8703(24)00235-7. doi: 10.1016/j.ahj.2024.
    >> Share

  34. MEFFORD MT, Ambrosy AP, Wei R, Zheng C, et al
    Rule-based natural language processing to examine variation in worsening heart failure hospitalizations by age, sex, race and ethnicity, and left ventricular ejection fraction.
    Am Heart J. 2024 Sep 7:S0002-8703(24)00234-5. doi: 10.1016/j.ahj.2024.
    >> Share

  35. LITWIN SE, Komtebedde J, Borlaug BA, Kaye DM, et al
    Long term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trials.
    Am Heart J. 2024 Sep 3:S0002-8703(24)00216-3. doi: 10.1016/j.ahj.2024.
    >> Share

  36. NELSON MD, Gomez-Arnold JM, Wei J, Lauzon M, et al
    Contributors to high left ventricular ejection fraction in women with ischemia and no obstructive coronary artery disease: Results from the Women's Ischemia Syndrome Evaluation - Coronary Vascular Dysfunction (WISE-CVD) Study.
    Am Heart J. 2024 Sep 2:S0002-8703(24)00224-2. doi: 10.1016/j.ahj.2024.
    >> Share

  37. BOCKUS LB, Shadman R, Poole JE, Dardas TF, et al
    Seattle proportional risk model in GISSI-HF: Estimated benefit of ICD in patients with EF less than 50.
    Am Heart J. 2024;275:35-44.
    >> Share

    August 2024
  38. LUNDBERG S, Knigge P, Strange JE, Nouhravesh N, et al
    Temporal trends in infection-related hospitalizations among patients with heart failure: A Danish nationwide study from 1997-2017.
    Am Heart J. 2024 Aug 29:S0002-8703(24)00219-9. doi: 10.1016/j.ahj.2024.
    >> Share

  39. ANDERSEN CF, Omar M, Larsen JH, Kistorp C, et al
    Accelerometer-Measured Physical Activity in Patients with Heart Failure and Reduced Ejection Fraction: Determinants and Relationship with Patient-Reported Health Status.
    Am Heart J. 2024 Aug 27:S0002-8703(24)00220-5. doi: 10.1016/j.ahj.2024.
    >> Share

  40. SANNA GD, Erre GL, Cameli M, Guerra F, et al
    Association of sex with in-hospital management and outcomes of patients with heart failure: data from the REAL-HF registry: The impact of sex in patients hospitalized for heart failure.
    Am Heart J. 2024 Aug 27:S0002-8703(24)00221-7. doi: 10.1016/j.ahj.2024.
    >> Share

  41. JIANG C, Wang Z, Du X, Wang Y, et al
    Protocol for a randomized controlled trial of intensive blood pressure control on cardiovascular risk reduction in patients with atrial fibrillation: rationale and design of the CRAFT trial.
    Am Heart J. 2024 Aug 23:S0002-8703(24)00203-5. doi: 10.1016/j.ahj.2024.
    >> Share

  42. FOX H
    Heart Failure and nocturnal hypoxemic burden, the connection is getting closer and closer.
    Am Heart J. 2024 Aug 21:S0002-8703(24)00207-2. doi: 10.1016/j.ahj.2024.
    >> Share

  43. LABARCA G
    Novel markers of nocturnal hypoxemia in sleep apnea and heart failure with reduced ejection fraction (HFrEF).
    Am Heart J. 2024 Aug 16:S0002-8703(24)00202-3. doi: 10.1016/j.ahj.2024.
    >> Share

  44. SOH CH, Wright L, Baumann A, Seidel B, et al
    Use of artificial intelligence-guided echocardiography to detect cardiac dysfunction and heart valve disease in rural and remote areas: Rationale and design of the AGILE-echo trial.
    Am Heart J. 2024;277:11-19.
    >> Share

  45. DISMORR M, Granbom-Koski M, Ellfors E, Ruck A, et al
    Sex differences and long-term clinical outcomes after transcatheter aortic valve replacement: a SWEDEHEART study.
    Am Heart J. 2024 Aug 9:S0002-8703(24)00185-6. doi: 10.1016/j.ahj.2024.
    >> Share

  46. MEDINA CK, Barnes SG, Felker GM, Mentz RJ, et al
    Severe obesity among patients with left ventricular assist devices.
    Am Heart J. 2024;274:130-133.
    >> Share

  47. ARRIGO M, Davison B, Edwards C, Adamo M, et al
    Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trial.
    Am Heart J. 2024;274:119-129.
    >> Share

    July 2024
  48. ABDUL-SAMAD K, Ma S, Austin DE, Chong A, et al
    Comparison of Machine Learning and Conventional Statistical Modeling for Predicting Readmission Following Acute Heart Failure Hospitalization.
    Am Heart J. 2024 Jul 31:S0002-8703(24)00183-2. doi: 10.1016/j.ahj.2024.
    >> Share

  49. BURGOS LM, Vila RCB, Ballari FN, Goyeneche A, et al
    Inferior vena CAVA and Lung UltraSound-guided therapy in Acute Heart Failure: a randomized pilot study (CAVAL US-AHF study).
    Am Heart J. 2024 Jul 31:S0002-8703(24)00181-9. doi: 10.1016/j.ahj.2024.
    >> Share

  50. SINGH K, Nikhare K, Gandral M, Aithal K, et al
    Rationale, Design and Baseline Characteristics of a Randomized Controlled Trial of a Cardiovascular Quality Improvement Strategy in India: The C-QIP Trial.
    Am Heart J. 2024 Jul 19:S0002-8703(24)00174-1. doi: 10.1016/j.ahj.2024.
    >> Share

  51. ELLFORS E, Dismorr M, Ruck A, Settergren M, et al
    Predicted prosthesis-patient mismatch and long-term clinical outcomes after transcatheter aortic valve replacement: a SWEDEHEART study.
    Am Heart J. 2024 Jul 18:S0002-8703(24)00175-3. doi: 10.1016/j.ahj.2024.
    >> Share

  52. PINNA GD, Maestri R, Robbi E, Guazzotti G, et al
    Nocturnal Hypoxemic Burden in Patients with Heart Failure: Emerging Prognostic Role of Its Non-Specific Component.
    Am Heart J. 2024 Jul 5:S0002-8703(24)00166-2. doi: 10.1016/j.ahj.2024.
    >> Share

    June 2024
  53. IBEH C, Kulick ER, Boehme AK, Friedman AM, et al
    Incident Stroke in Individuals with Peripartum Cardiomyopathy.
    Am Heart J. 2024 Jun 20:S0002-8703(24)00160-1. doi: 10.1016/j.ahj.2024.
    >> Share

  54. PICHAN CM, Santivasi WL, Mentz RJ
    A Bridge to Comfort: Palliative Inotrope Infusion for Patients with Heart Failure in Hospice Care.
    Am Heart J. 2024 Jun 15:S0002-8703(24)00159-5. doi: 10.1016/j.ahj.2024.
    >> Share

    May 2024
  55. KUSNER J, Patel RB, Hu M, Bertoni AG, et al
    Association of Disproportionate Liver Fat with Markers of Heart Failure: The Multi-Ethnic Study of Atherosclerosis.
    Am Heart J. 2024 May 20:S0002-8703(24)00125-X. doi: 10.1016/j.ahj.2024.
    >> Share

  56. KITTIPIBUL V, Yaranov DM, Biegus J, Gray JM, et al
    Prognostic implications of volume status assessed by blood volume analysis in ambulatory heart failure.
    Am Heart J. 2024;271:178-181.
    >> Share

    April 2024
  57. ELKHOLEY K, Asad ZUA, Shehata E, Mustafina I, et al
    Association between atrial fibrillation and heart failure patient reported outcomes across the ejection fraction spectrum.
    Am Heart J. 2024 Apr 27:S0002-8703(24)00104-2. doi: 10.1016/j.ahj.2024.
    >> Share

  58. GAGNON LR, Hazra D, Perera K, Wang K, et al
    Uptake of SGLT2i and Outcomes in Patients with Diabetes and Heart Failure: A Population-Based Cohort and a Specialized Clinic Cohort.
    Am Heart J. 2024 Apr 24:S0002-8703(24)00094-2. doi: 10.1016/j.ahj.2024.
    >> Share

  59. HAMO CE, Mukhopadhyay A, Li X, Zheng Y, et al
    Association between Visit Frequency, Continuity of Care, and Pharmacy Fill Adherence in Heart Failure Patients.
    Am Heart J. 2024 Apr 13:S0002-8703(24)00090-5. doi: 10.1016/j.ahj.2024.
    >> Share

  60. KEEPANASSERIL A, Pande SN, Suriya Y, Baghel J, et al
    "Comparing the Outcomes of Rheumatic Heart Disease in Pregnancy Complicated with and without Atrial Fibrillation: A Propensity Score Matched Analysis".
    Am Heart J. 2024 Apr 11:S0002-8703(24)00089-9. doi: 10.1016/j.ahj.2024.
    >> Share

  61. MANJA V, Sandhu ATS, Asch S, Frayne S, et al
    Healthcare utilization and left ventricular ejection fraction distribution in methamphetamine use associated heart failure hospitalizations.
    Am Heart J. 2024;270:156-160.
    >> Share

  62. SMOLDEREN KG, Romain G, Cleman J, Scierka L, et al
    Variability in guideline-directed medical therapy across sites and operators and long-term mortality and amputation outcomes risk in patients undergoing peripheral vascular interventions.
    Am Heart J. 2024;270:75-85.
    >> Share

    March 2024
  63. ZHANG L, Wang W, Huo X, He G, et al
    Predicting the risk of 1-year mortality among patients hospitalized for acute heart failure in China.
    Am Heart J. 2024 Mar 13:S0002-8703(24)00066-8. doi: 10.1016/j.ahj.2024.
    >> Share

  64. SAMPAIO RODRIGUES T, Garcia Quarto LJ, Nogueira SC, Theuerle JD, et al
    Door-to-diuretic time and mortality in patients with acute heart failure: A systematic review and meta-analysis.
    Am Heart J. 2024;269:205-209.
    >> Share

    February 2024
  65. SZABO B, Benson L, Savarese G, Hage C, et al
    Previous heart failure hospitalization, spironolactone and outcomes in heart failure with preserved ejection fraction - a secondary analysis of TOPCAT.
    Am Heart J. 2024 Feb 25:S0002-8703(24)00048-6. doi: 10.1016/j.ahj.2024.
    >> Share

  66. RAO VN, Sharma A, Stebbins A, Buse JB, et al
    Regional variation in cause of death in patients with type 2 diabetes: insights from EXSCEL: Cause of Death in Type 2 Diabetes.
    Am Heart J. 2024 Feb 21:S0002-8703(24)00040-1. doi: 10.1016/j.ahj.2024.
    >> Share

  67. ANDERSEN CF, Larsen JH, Jensen J, Omar M, et al
    Empagliflozin to elderly and obese patients with increased risk of developing heart failure: Study protocol for the Empire Prevent trial program.
    Am Heart J. 2024 Feb 14:S0002-8703(24)00032-2. doi: 10.1016/j.ahj.2024.
    >> Share

  68. LAMP J, Wu Y, Lamp S, Afriyie P, et al
    Characterizing Advanced Heart Failure Risk and HemodyNAmic Phenotypes using Interpretable Machine Learning.
    Am Heart J. 2024 Feb 7:S0002-8703(24)00021-8. doi: 10.1016/j.ahj.2024.
    >> Share

    January 2024
  69. ZEITLER EP, Dalgaard F, Abraham WT, Cleland JGF, et al
    Benefit of cardiac resynchronization therapy among older patients: A patient-level meta-analysis.
    Am Heart J. 2024;267:81-90.
    >> Share

  70. ROLFS N, Huber C, Schwarzkopf E, Mentzer D, et al
    Clinical course and follow-up of pediatric patients with COVID-19 vaccine-associated myocarditis compared to non-vaccine-associated myocarditis within the prospective multicenter registry-"MYKKE".
    Am Heart J. 2024;267:101-115.
    >> Share

    December 2023
  71. SALERNO PR, Chen Z, Wass S, Motairek I, et al
    Sex-specific Heart Failure Burden Across the United States: Global Burden of Disease 1990-2019.
    Am Heart J. 2023 Dec 16:S0002-8703(23)00348-4. doi: 10.1016/j.ahj.2023.
    >> Share

  72. SIREN M, Leivo J, Anttonen E, Jolly SS, et al
    The Prognostic Significance of Single-Lead ST-Segment Resolution in ST-Segment Elevation Myocardial Infarction Patients Treated with Primary PCI - A Substudy of the Randomized TOTAL Trial.
    Am Heart J. 2023 Dec 16:S0002-8703(23)00347-2. doi: 10.1016/j.ahj.2023.
    >> Share

  73. MONTEMBEAU SC, Rao BR, Mitchell AR, Speight CD, et al
    Integrating Cost into Shared Decision-Making for Heart Failure with Reduced Ejection Fraction (POCKET-COST-HF): A Trial Providing Out-of-pocket Costs for Heart Failure Medications during Clinical Encounters.
    Am Heart J. 2023 Dec 12:S0002-8703(23)00322-8. doi: 10.1016/j.ahj.2023.
    >> Share

  74. GUNN AH, Warraich HJ, Mentz RJ
    Costs of Care and Financial Hardship Among Patients with Heart Failure.
    Am Heart J. 2023 Dec 6:S0002-8703(23)00330-7. doi: 10.1016/j.ahj.2023.
    >> Share

    November 2023
  75. SAVARESE G, Gatti P, Benson L, Adamo M, et al
    LEFT VENTRICULAR EJECTION FRACTION DIGIT BIAS AND RECLASSIFICATION OF HEART FAILURE WITH MILDLY REDUCED VS. REDUCED EJECTION FRACTION BASED ON THE 2021 DEFINITION AND CLASSIFICATION OF HEART FAILURE: Abbreviated title: DIGIT BIAS AND HEART FAILURE REC
    Am Heart J. 2023 Nov 14:S0002-8703(23)00317-4. doi: 10.1016/j.ahj.2023.
    >> Share

  76. STRANGE JE, Nouhravesh N, Schou M, Christensen DM, et al
    High-risk admission prior to transcatheter aortic valve replacement and subsequent outcomes: Preceding events and outcomes after TAVR.
    Am Heart J. 2023 Nov 14:S0002-8703(23)00311-3. doi: 10.1016/j.ahj.2023.
    >> Share

  77. SALAHUDDIN T, Hebbe A, Daus M, Essien UR, et al
    Trends and Site-level Variation of Novel Cardiovascular Medication Utilization among Patients Admitted for Heart Failure or Coronary Artery Disease in the US Veterans Affairs System: 2017-2021.
    Am Heart J. 2023 Nov 11:S0002-8703(23)00318-6. doi: 10.1016/j.ahj.2023.
    >> Share

    October 2023
  78. EGBE AC, Miranda WR, Jain CC, Stephens EH, et al
    Temporal Changes in Clinical Characteristics and Outcomes of Adults With Congenital Heart Disease.
    Am Heart J. 2023;264:1-9.
    >> Share

    September 2023
  79. FLETT A, Cebula A, Nicholas Z, Adam R, et al
    Rationale and study protocol for the BRITISH randomised trial (Using cardiovascular magnetic resonance identified scar as the Benchmark Risk Indication Tool for Implantable cardioverter defibrillators in patients with Non-Ischaemic Cardiomyopathy and
    Am Heart J. 2023 Sep 28:S0002-8703(23)00281-8. doi: 10.1016/j.ahj.2023.
    >> Share

    August 2023
  80. JAMES S, Erlinge D, Storey RF, McGuire DK, et al
    Rationale and design of the DAPA-MI trial: Dapagliflozin in patients without diabetes mellitus with acute myocardial infarction.
    Am Heart J. 2023 Aug 25:S0002-8703(23)00207-7. doi: 10.1016/j.ahj.2023.
    >> Share

  81. HARRINGTON J, Mentz RJ, Rockhold FW, Garg J, et al
    Baseline Characteristics of Patients in the Randomized Study to Investigate the Efficacy and Safety of Ferric Carboxymaltose as Treatment for Heart Failure with Iron Deficiency: HEART-FID Trial.
    Am Heart J. 2023 Aug 18:S0002-8703(23)00202-8. doi: 10.1016/j.ahj.2023.
    >> Share

  82. COX ZL, Siddiqi HK, Stevenson LW, Bales B, et al
    Randomized controlled trial of urinE chemiStry guided aCute heArt faiLure treATmEnt (ESCALATE): Rationale and design.
    Am Heart J. 2023 Aug 4:S0002-8703(23)00187-4. doi: 10.1016/j.ahj.2023.
    >> Share

    July 2023
  83. VINEREANU D, Wojdyla DM, Alexander JH, Lopes RD, et al
    Heart Rate and Death and Hospitalization for Heart Failure in Patients with Persistent or Permanent Atrial Fibrillation: Insights from the ARISTOTLE Trial.
    Am Heart J. 2023 Jul 26:S0002-8703(23)00179-5. doi: 10.1016/j.ahj.2023.
    >> Share

  84. MATASIC DS, Blumenthal RS, Fonarow GC, Gulati M, et al
    Taking the next step in cardiovascular risk reduction: Integrating heart failure and peripheral arterial disease prevention.
    Am Heart J. 2023 Jul 20:S0002-8703(23)00176-X. doi: 10.1016/j.ahj.2023.
    >> Share

  85. BANKE A, Andersson C, D'Souza M, Fosbol E, et al
    Importance of familial predisposition to heart failure to the risk of anthracycline related cardiotoxicity: A nationwide study.
    Am Heart J. 2023 Jul 13:S0002-8703(23)00175-8. doi: 10.1016/j.ahj.2023.
    >> Share

  86. JEFFERIES JL, Kovesdy CP, Ronco C
    Contemporary laboratory assessment of acute cardiorenal syndrome for early diagnosis: A call for action.
    Am Heart J. 2023;261:75-84.
    >> Share

  87. PETERS AE, Solomon N, Chiswell K, Fonarow GC, et al
    Transthyretin Amyloid Cardiomyopathy Among Patients Hospitalized for Heart Failure and Performance of an Adapted Wild-Type ATTR-CM Machine Learning Model: Findings from GWTG-HF.
    Am Heart J. 2023 Jul 1:S0002-8703(23)00169-2. doi: 10.1016/j.ahj.2023.
    >> Share

    June 2023
  88. GANGAVELLI A, Liu Z, Wang J, Okoh A, et al
    Racial Differences in Low Natriuretic Peptide Levels: Implications for Heart Failure Clinical Trials.
    Am Heart J. 2023 Jun 19:S0002-8703(23)00163-1. doi: 10.1016/j.ahj.2023.
    >> Share

  89. VIOLI F, Castellani V, Menichelli D, Pignatelli P, et al
    GUT BARRIER DYSFUNCTION AND ENDOTOXEMIA IN HEART FAILURE: A DANGEROUS CONNUBIUM?
    Am Heart J. 2023 Jun 8:S0002-8703(23)00146-1. doi: 10.1016/j.ahj.2023.
    >> Share

  90. MEWTON N, Donal E, Picard F, Derimay F, et al
    Prognostic impact of precipitated cardiac decompensation in symptomatic heart failure with reduced ejection fraction and severe secondary mitral regurgitation.
    Am Heart J. 2023 Jun 2:S0002-8703(23)00137-0. doi: 10.1016/j.ahj.2023.
    >> Share

    May 2023
  91. KRONBORG MB, Frausing MHJP, Svendsen JH, Johansen JB, et al
    Does Targeted Positioning of the Left Ventricular Pacing Lead Towards the Latest Local Electrical Activation in Cardiac Resynchronization Therapy Reduce the Incidence of Death or Hospitalization for Heart Failure?
    Am Heart J. 2023 May 21:S0002-8703(23)00129-1. doi: 10.1016/j.ahj.2023.
    >> Share

  92. ARNOLD SV, Gosch K, Kosiborod M, Wong ND, et al
    Contemporary Use of Cardiovascular Risk Reduction Strategies in Type 2 Diabetes. Insights from The Diabetes Collaborative Registry.
    Am Heart J. 2023 May 8:S0002-8703(23)00112-6. doi: 10.1016/j.ahj.2023.
    >> Share

  93. CHOUAIRI F, Pinsker B, Miller PE, Fudim M, et al
    Effects of COVID-19 on Heart Failure Admissions.
    Am Heart J. 2023 May 6:S0002-8703(23)00111-4. doi: 10.1016/j.ahj.2023.
    >> Share

  94. SELAMET TIERNEY ES, Palaniappan L, Leonard M, Long J, et al
    Design and rationale of re-energize fontan: Randomized exercise intervention designed to maximize fitness in fontan patients.
    Am Heart J. 2023;259:68-78.
    >> Share

    April 2023
  95. RAO VN, Cyr D, Wruck L, Sanders G, et al
    Electronic Health Record Characterization and Outcomes of Heart Failure with Preserved Ejection Fraction.
    Am Heart J. 2023 Apr 26:S0002-8703(23)00100-X. doi: 10.1016/j.ahj.2023.
    >> Share

  96. FU G, Zhou Z, Jian B, Huang S, et al
    Systolic blood pressure time in target range and long-term outcomes in patients with ischemic cardiomyopathy.
    Am Heart J. 2023;258:177-185.
    >> Share

  97. JOHNSON M, Morrison FJ, McMahon G, Su M, et al
    Outcomes in patients with cardiometabolic disease who develop hyperkalemia while treated with a renin-angiotensin-aldosterone system inhibitor.
    Am Heart J. 2023;258:49-59.
    >> Share

  98. MUKHOPADHYAY A, Reynolds HR, Xia Y, Phillips LM, et al
    Design and pilot implementation for the BETTER CARE-HF trial: A pragmatic cluster-randomized controlled trial comparing two targeted approaches to ambulatory clinical decision support for cardiologists.
    Am Heart J. 2023;258:38-48.
    >> Share

    February 2023
  99. UPSHAW JN, Parker S, Gregory D, Koethe B, et al
    The effect of tablet computer-based telemonitoring added to an established telephone disease management program on heart failure hospitalizations: The Specialized Primary and Networked Care in Heart Failure (SPAN-CHF) III Randomized Controlled Trial.
    Am Heart J. 2023 Feb 24:S0002-8703(23)00042-X. doi: 10.1016/j.ahj.2023.
    >> Share

  100. YAKU H, Kato T, Morimoto T, Kaneda K, et al
    Rationale and Study design of the GOREISAN for Heart Failure (GOREISAN-HF) trial: A randomized clinical trial.
    Am Heart J. 2023 Feb 23:S0002-8703(23)00045-5. doi: 10.1016/j.ahj.2023.
    >> Share

    January 2023
  101. SILVAIN J, Cayla G, Ferrari E, Range G, et al
    betaeta Blocker Interruption after Uncomplicated Myocardial Infarction: Rationale and Design of the randomized ABYSS trial.
    Am Heart J. 2023 Jan 19:S0002-8703(23)00021-2. doi: 10.1016/j.ahj.2023.
    >> Share

    October 2021
  102. COTTER G, Davison BA, Edwards C, Senger S, et al
    Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials.
    Am Heart J. 2021;240:73-80.
    >> Share

    June 2021
  103. SZUMMER K, Perino AC, Fan J, Kothari M, et al
    Association of kidney function and atrial fibrillation progression to clinical outcomes in patients with cardiac implantable electronic devices.
    Am Heart J. 2021 Jun 9. pii: S0002-8703(21)00149.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016